Jasmine Dale, MAcc is an accounting professional with nearly 10 years experience in accounting and financial consulting. She was formerly a Senior Corporate Accountant, then Finance Consultant, with Sentara Healthcare, the largest integrated health system in the United States. During her time at Sentara, she served as the lead resource of financial data and analysis for multiple ambulatory business lines. Prior to working for Sentara, Ms. Dale was an auditor at a regional accounting firm and at Deloitte, one of the largest professional accounting organizations in the world. Ms. Dale received her B.A. in Accounting at Seattle University and her Master of Accountancy from the University of Denver – she currently holds a CPA license in the state of Virginia.

Heather V. Gray, Esq. is a former senior research associate with the Institute for Intergovernmental Research (IIR) where she worked on the Bureau of Justice Assistance (BJA) Comprehensive Opioid Abuse Program, supporting the Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC).  Her responsibilities included legislative research and analysis on prescription monitoring programs and other opioid-related legislation and provision of training and technical assistance to the field on needs related to the establishment and operation of a PDMP. Prior to her work at IIR, Ms. Gray served as a consultant on legal and legislative matters, as well as drafting and editing materials and consulting on various matters regarding alcohol, controlled substances, health care, and criminal justice. Ms. Gray also served as a research and legislative attorney for the National Alliance for Model State Drug Laws.  In this capacity, she conducted research and analysis of statutes, regulations, guidelines, and other materials related to drugs and alcohol.  She also drafted, and assisted others with the drafting of, model laws. Ms. Gray received her juris doctorate degree from the University of Memphis, Cecil C. Humphreys School of Law.  She is a member of the State of Tennessee Bar.

Sarah Kelsey, Esq. is the co-founder and Chief Executive Officer (CEO) of the Legislative Analysis and Public Policy Association (LAPPA), where much of her recent work has focused on controlled substances including prescribing practices, safe consumption sites, emerging drugs of concern, prescription monitoring programs, pain clinic laws/regulations, and other related topics. Prior to forming LAPPA, Ms. Kelsey was the CEO of the National Alliance for Model State Drug Laws (NAMSDL), a resource for governors, legislators, attorneys general, prosecutors, drug and alcohol professionals, health professionals, community leaders, the recovering community and others who strive for comprehensive and effective state drug and alcohol laws, policies, regulations, and programs. During her tenure with NAMSDL, first as a research and legislative attorney and then as CEO, Ms. Kelsey specialized in the retrieval, review, analysis, and comparison of each of the states’ drug and alcohol laws. Ms. Kelsey received her B.A. in Government Affairs from the University of Virginia and her J.D. from the Columbus School of Law at Catholic University. She is a member of the Maryland State Bar Association.

Joseph M. Maschman, Esq. is a former legal fellow at the democracy reform nonprofit Common Cause, where he focused on money in politics and government ethics. There he drafted model legislation, filed complaints for violations of campaign finance law before the Federal Election Commission, and wrote public reports on democracy reform policy. He has also worked in campaign finance on multiple political campaigns and has vetted federal judicial nominees for a civil rights organization. Mr. Maschman received his B.A. in Political Science from Creighton University and his Juris Doctor from the Georgetown University Law Center. He is a member of the bar of the Commonwealth of Virginia.

Cody Nagle, JD is a former advisor for the White House Office of National Drug Control Policy (ONDCP) where she worked in public engagement on issues of substance use disorder recovery, criminal justice reform and stigma reduction. As one of the first formerly incarcerated individuals to serve in the Executive Office of the President, Ms. Nagle engaged with faith leaders, businesses, families of overdose victims and youth, to advocate and educate about the harms of stigma in ending the nation’s overdose epidemic. Cody also helped to launch the National Recovery Friendly Workplace Institute. Ms. Nagle started her legal career in private practice as a paralegal in civil litigation practice prior to attending law school. She is a recent graduate of Syracuse University College of Law, where she served on the Executive Board for the Journal for Global Rights and Organizations. Cody brings unique expertise to LAPPA as a woman in long-term recovery.

Stephanie Noblit, Esq., MLS (ASCP)^CM received her J.D. from Drexel University’s Thomas R. Kline School of Law in 2019.  She concentrated in health law and graduated cum laude.  While in law school, she worked pro bono for the Medical Legal Community Partnership where she assisted patients at Philadelphia’s public health centers with applying for medical assistance, SNAP, and other public benefits.  In addition to her Esq., Stephanie is also a certified medical laboratory scientist.  She received her B.S. in medical laboratory science from the University of the Sciences and worked in the clinical toxicology laboratory at the Hospital of the University of Pennsylvania prior to starting law school.  In this position, Stephanie performed drugs of abuse testing and therapeutic drug monitoring. She is a member of the Commonwealth of Pennsylvania Bar Association.

Susan P. Weinstein, Esq. is the co-founder and president of the Legislative Analysis and Public Policy Association (LAPPA) and has almost 30 years of experience with drug and drug-related topics. Prior to forming LAPPA, she was a court consultant for the National Center for State Courts where she oversaw the civil and criminal justice work group of the National Judicial Opioid Task Force. Prior to that, she owned her own consulting firm where she assisted various organizations on issues including legal and legislative affairs and other matters regarding criminal law and substance use. She was also the Director of State and Federal Affairs for the National Alliance for Model State Drug Laws, the Chief Counsel for the National Association of Drug Court Professionals, and worked in the criminal prosecution division of the National District Attorneys Association. She has authored numerous publications and presented at various conferences on the intersection of criminal law and substance use. Ms. Weinstein received her Juris Doctorate, magna cum laude, from Syracuse University’s College of Law and her Bachelor of Business Administration from the George Washington University. She is a member of the bars of the Commonwealth of Pennsylvania, the State of New Jersey, and the District of Columbia.

Jonathan S. Woodruff, Esq. has numerous years of experience researching and analyzing state and federal criminal justice and health care issues involving, among other things, novel psychoactive substances/controlled substance analogues, naloxone access, the warm-hand off of overdose survivors to treatment, drugged driving, ethical substance use disorder treatment practices, and the recreational and medicinal use of marijuana. He is a former Senior Legislative Attorney at the National Alliance for Model State Drug Laws, where he drafted model state legislation and created many subject matter analyses published to the NAMSDL website. Prior to joining NAMSDL, Mr. Woodruff was a private practice attorney in Virginia and the District of Columbia, as well as an insurance company actuary in Illinois. Mr. Woodruff received a B.A. in Physics from Illinois Wesleyan University, and a J.D. from the University of Virginia School of Law, where he was a member of the Virginia Law Review. He is an associate member of the Virginia and District of Columbia Bar Associations.